We are live on ! Find out more
KRON

Kronos Bio
KRON

Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings

71 hedge funds and large institutions have $1.05B invested in Kronos Bio in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.38% more ownership

Funds ownership: 60.89% → 64.27% (+3.4%)

4% more capital invested

Capital invested by funds: $1.01B → $1.05B (+$43.8M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0% more call options, than puts

Call options by funds: $2K | Put options by funds: $2K

1% less funds holding

Funds holding: 72 → 71 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

18% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 22

Holders
71
Holders Change
-1
Holders Change %
-1.39%
% of All Funds
1.25%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
6
Increased
18
Reduced
22
Closed
7
Calls
$2K
Puts
$2K
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
+$58.2M
2
Victory Capital Management
Victory Capital Management
Texas
+$11.5M
3
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$6.95M
4
UBS AM
UBS AM
Illinois
+$4.44M
5
BlackRock
BlackRock
New York
+$3.19M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.5M
2
Invesco
Invesco
Georgia
-$3.88M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.99M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.46M
5
SFM
Sphera Funds Management
Israel
-$1.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
26
Franklin Resources
California
$5.85M – – –
WP
27
Woodline Partners
California
$5.5M -$978K -33,402 -15%
DP
28
DSAM Partners
United Kingdom
$5.19M -$664K -22,670 -11%
SB
29
Samsara BioCapital
California
$4.87M – – –
Northern Trust
30
Northern Trust
Illinois
$4.75M -$222K -7,569 -4%
UBS AM
31
UBS AM
Illinois
$4.44M +$4.44M +151,634 New
OCA
32
Octagon Capital Advisors
New York
$4.28M – – –
PAMU
33
Pictet Asset Management (UK)
United Kingdom
$3M +$138K +4,720 +5%
Morgan Stanley
34
Morgan Stanley
New York
$2.98M -$294K -10,032 -9%
Charles Schwab
35
Charles Schwab
California
$2.79M +$118K +4,020 +4%
N
36
Nuveen
North Carolina
$1.56M +$3.9K +133 +0.2%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.13M +$36.3K +1,238 +3%
Ameriprise
38
Ameriprise
Minnesota
$1.05M -$228K -7,779 -18%
TD Asset Management
39
TD Asset Management
Ontario, Canada
$961K +$94.5K +3,225 +11%
B
40
Bailard
California
$907K +$908K +31,000 New
Cerity Partners
41
Cerity Partners
New York
$878K +$879K +30,000 New
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$793K -$74.7K -2,549 -9%
HS
43
HighVista Strategies
Massachusetts
$789K +$789K +26,944 New
Millennium Management
44
Millennium Management
New York
$732K -$932K -31,815 -56%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$662K +$15.2K +519 +2%
Goldman Sachs
46
Goldman Sachs
New York
$541K -$705K -24,051 -57%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$445K +$59.6K +2,034 +15%
HighTower Advisors
48
HighTower Advisors
Illinois
$439K – – –
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$386K +$52.7K +1,800 +16%
Bank of America
50
Bank of America
North Carolina
$367K +$219K +7,482 +148%
1
2
3 4

KRON Hedge Fund Activity: Q1 2021 in Review

71 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q1 2021, worth a combined $1.05B — up 4.4% from $1.01B a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of KRON and 6 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 18 added.

The largest buyer was Capital World Investors, opening a new position worth an estimated $58.2M. The largest seller was Fidelity Investments, cutting an estimated $17.5M.

  • 71 institutional investors held Kronos Bio (KRON) as of Q1 2021, down from 72 in Q4 2020.
  • Funds reported $1.05B of Kronos Bio stock for Q1 2021, up 4.4% quarter-over-quarter.
  • 6 funds opened new Kronos Bio positions in Q1 2021 and 7 closed out, a net change of -1 holder.
  • The largest Kronos Bio buyer in Q1 2021 was Capital World Investors, an estimated $58.2M added.
  • The largest Kronos Bio seller in Q1 2021 was Fidelity Investments, an estimated $17.5M sold.

Based on aggregated 13F filings for Q1 2021.